Fabrazyme 35 MG vials
Ended Awarded
- Contract number
- SPE2DB26FY19B
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,276
Award facts
- Contract value 100% obligated
- $11,276.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,276.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fabrazyme 35 mg vials. The delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. DMS Pharmaceutical Group is performing all work at its Park Ridge facility without identified subcontractor involvement.
This delivery order is issued under DMS Pharmaceutical Group's newly awarded Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499,999,999 ceiling value and extends through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to supply comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across multiple therapeutic categories and product lines positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FY19B?
SPE2DB26FY19B was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FY19B worth?
The government has obligated $11,276 on SPE2DB26FY19B.
Is contract SPE2DB26FY19B an order under another contract?
Yes. SPE2DB26FY19B is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB26FY19B competed?
The extent of competition for SPE2DB26FY19B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award